Nathalie Garcon
Biography
Nathalie Garçon currently serves as the CSO for Technology research institute BIOASTER, dealing with technologies to accelerate the development and availability of new solutions in infectiology. Previously, Dr Garcon served as the Vice President and Head of Global Adjuvant and technologies innovation centers at GSK vaccines. Following the successful completion of two PhDs, one in biological pharmacy and the other in immunotoxicology and immunopharmacology, Dr Garçon moved to the UK for 1 year as a postdoctoral research fellow at the Royal Free Hospital in London, undertaking research on liposomes in vaccines.
Research Interest
Dr Garçon’s expertise in vaccinology extends from research to manufacturing, in particular immunology, adjuvant and formulation technologies, analytical methods, animal experimentation and toxicology/safety evaluation and testing.